Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006653 citationsJann Arends, G. Bodoky et al.Clinical Nutritionprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of E. Aulbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Aulbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Aulbert more than expected).
This network shows the impact of papers produced by E. Aulbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Aulbert. The network helps show where E. Aulbert may publish in the future.
Co-authorship network of co-authors of E. Aulbert
This figure shows the co-authorship network connecting the top 25 collaborators of E. Aulbert.
A scholar is included among the top collaborators of E. Aulbert based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with E. Aulbert. E. Aulbert is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Arends, Jann, G. Bodoky, Federico Bozzetti, et al.. (2006). ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clinical Nutrition. 25(2). 245–259.653 indexed citations breakdown →
Aulbert, E., et al.. (1990). [Beta 2 microglobulin in serum--a "tumor marker" in malignant lymphomas?].. PubMed. 85(1). 13–7.9 indexed citations
7.
Aulbert, E.. (1989). [Anemia in malignant tumor diseases. I. Tumor-induced loss of transferrin and its relation to tumor size and degree of malignancy in the rat model].. PubMed. 28(5). 193–200.1 indexed citations
Aulbert, E.. (1989). [Anemia in malignant tumor diseases. II. Tumor-induced loss of transferrin as a cause of the development of anemia based on a rat model].. PubMed. 28(6). 247–54.2 indexed citations
10.
Aulbert, E., et al.. (1989). [Anemia in malignant tumor diseases. VI. Secondary siderosis caused by the shift of iron, unused for hemoglobin synthesis, into iron stores].. PubMed. 84(9). 421–8.1 indexed citations
11.
Höffken, K., et al.. (1986). [Low-dose aminoglutethimide therapy without cortisol substitution in postmenopause metastasizing breast cancer].. PubMed. 81(20). 638–42.4 indexed citations
Aulbert, E., et al.. (1976). The effect of Ca ion antagonist verapamil on ouabain inhibition of renal sodium reabsorption. Studies in the isolated perfused rat kidney.. PubMed. 6. 281–90.7 indexed citations
Aulbert, E., et al.. (1975). Influence of ouabain and ethacrynic acid on sodium transport and NaK-ATPase activity in the isolated perfused rat kidney.. PubMed. 4. 162–8.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.